Raymond James & Associates’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $509K | Buy |
22,395
+10,955
| +96% | +$249K | ﹤0.01% | 3085 |
|
|
2024
Q2 | $149K | Sell |
11,440
-109
| -0.9% | -$1.42K | ﹤0.01% | 3633 |
|
|
2024
Q1 | $202K | Buy |
11,549
+1,321
| +13% | +$23.1K | ﹤0.01% | 3581 |
|
|
2023
Q4 | $223K | Sell |
10,228
-4,936
| -33% | -$108K | ﹤0.01% | 3431 |
|
|
2023
Q3 | $233K | Buy |
15,164
+6,303
| +71% | +$96.7K | ﹤0.01% | 3356 |
|
|
2023
Q2 | $211K | Sell |
8,861
-278
| -3% | -$6.61K | ﹤0.01% | 3425 |
|
|
2023
Q1 | $232K | Buy |
+9,139
| New | +$232K | ﹤0.01% | 3377 |
|
|
2018
Q4 | – | Sell |
-1,495
| Closed | -$125K | – | 3559 |
|
|
2018
Q3 | $125K | Buy |
1,495
+88
| +6% | +$7.36K | ﹤0.01% | 3364 |
|
|
2018
Q2 | $135K | Buy |
+1,407
| New | +$135K | ﹤0.01% | 3322 |
|